2015
DOI: 10.1016/j.cellimm.2015.05.007
|View full text |Cite
|
Sign up to set email alerts
|

The paradoxical role of IL-17 in atherosclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
34
0
1

Year Published

2016
2016
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 58 publications
(38 citation statements)
references
References 80 publications
3
34
0
1
Order By: Relevance
“…Our data are comparable with a previous study that had demonstrated that ApoE Ϫ/Ϫ mice treated with anti-mouse IL-17A had no significant changes in atherosclerotic plaque burden relative to the control mice (44). We believe that this observation is presumably due to alteration of the lipid profiles seen in ApoE Ϫ/Ϫ /IL-17A Ϫ/Ϫ mice.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…Our data are comparable with a previous study that had demonstrated that ApoE Ϫ/Ϫ mice treated with anti-mouse IL-17A had no significant changes in atherosclerotic plaque burden relative to the control mice (44). We believe that this observation is presumably due to alteration of the lipid profiles seen in ApoE Ϫ/Ϫ /IL-17A Ϫ/Ϫ mice.…”
Section: Discussionsupporting
confidence: 90%
“…Previous studies of the role of IL-17 in atherogenesis have reported contradictory results; therefore, the role of IL-17 in atherogenesis remained controversial (44). These reports have claimed that IL-17 either had no atherosclerosis-regulatory effect (25), had a proatherosclerotic effect (26), or showed an antiatherosclerotic effect (27).…”
Section: Discussionmentioning
confidence: 99%
“…However, it has also been reported that a deficiency of IL-17 could result in vulnerable plaque by reducing collagen and VSMCs. Similar unclear results have been reported in other studies (198)(199)(200)(201)(202). Further studies are needed to elucidate the roles of IL-17 in atherosclerosis.…”
Section: Inflammationsupporting
confidence: 80%
“…Studies showed that JNK pathway is critical for foam cell formation (32). The role of IL-17, an upstream activator of TRAF3IP2, in atherosclerosis is inconclusive, as the studies demonstrated contrasting effects (16). Though, cell-specific inhibition of signaling molecules regulated by TRAF3IP2 have shown divergent outcomes on plaque stability, alteration of these pathways by global knockdown of TRAF3IP2 might have altered signaling cascades towards increased plaque stability.…”
Section: Discussionmentioning
confidence: 99%